| Market Cap | 21.99M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -14.04M | Forward P/E | -45.75 | EPS next Y | - | 50D Avg Chg | 21.00% |
| Sales | 1.75M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -11.00% |
| Dividend | N/A | Price/Book | 1.17 | EPS next 5Y | - | 52W High Chg | -60.00% |
| Recommedations | 2.00 | Quick Ratio | 1.24 | Shares Outstanding | 6.67M | 52W Low Chg | 122.00% |
| Insider Own | 2.16% | ROA | -55.80% | Shares Float | 6.41M | Beta | 1.14 |
| Inst Own | 4.33% | ROE | -149.36% | Shares Shorted/Prior | 64.05K/81.08K | Price | 5.49 |
| Gross Margin | 60.24% | Profit Margin | - | Avg. Volume | 152,414 | Target Price | 3.00 |
| Oper. Margin | -1,144.24% | Earnings Date | Nov 12 | Volume | 50,988 | Change | -5.02% |
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.
| HC Wainwright & Co. | Buy | Aug 19, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Nuzum Charles Lee Sr | Director Director | Sep 25 | Sell | 3.0387 | 10,000 | 30,387 | 24,033 | 09/27/23 |
| HANDLEY DANIEL E | Director Director | Dec 15 | Buy | 0.4100 | 6,000 | 2,460 | 120,513 | 12/15/22 |
| MYERS ROBERT L | CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER | Dec 02 | Buy | 0.5686 | 8,795 | 5,001 | 71,265 | 12/02/22 |
| Vennare Raymond F | Director Director | Dec 02 | Buy | 0.52 | 5,000 | 2,600 | 83,730 | 12/02/22 |
| HANDLEY DANIEL E | Director Director | Nov 29 | Buy | 0.3578 | 10,000 | 3,578 | 114,513 | 11/30/22 |
| HANDLEY DANIEL E | Director Director | May 26 | Buy | 0.3747 | 2,550 | 955 | 49,666 | 05/27/22 |
| HANDLEY DANIEL E | Director Director | May 25 | Buy | 0.35 | 2,800 | 980 | 47,116 | 05/25/22 |
| ENGLE J MELVILLE | Director Director | May 24 | Buy | 0.372 | 159,500 | 59,334 | 203,393 | 05/24/22 |